Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human Ovarian Cancer Cells
Open Access
- 28 November 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 17, 5697-5731
Abstract
Background: Exosomes, which are nanovesicles secreted by almost all the cells, mediate intercellular communication and are involved in various physiological and pathological processes. We aimed to investigate the effects of graphene oxide (GO) on the biogenesis and release of exosomes in human ovarian cancer (SKOV3) cells. Methods: Exosomes were isolated using ultracentrifugation and ExoQuick and characterized by various analytical techniques. The expression levels of exosome markers were analyzed via quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay. Results: Graphene oxide (10– 50 μg/mL), cisplatin (2– 10 μg/mL), and C6-ceramide (5– 25 μM) inhibited the cell viability, proliferation, and cytotoxicity in a dose-dependent manner. We observed that graphene oxide (GO), cisplatin (CIS), and C6-Ceramide (C6-Cer) stimulated acetylcholine esterase and neutral sphingomyelinase activity, total exosome protein concentration, and exosome counts associated with increased level of apoptosis, oxidative stress and endoplasmic reticulum stress. In contrast, GW4869 treatment inhibits biogenesis and release of exosomes. We observed that the human ovarian cancer cells secreted exosomes with typical cup-shaped morphology and surface protein biomarkers. The expression levels of TSG101, CD9, CD63, and CD81 were significantly higher in GO-treated cells than in control cells. Further, cytokine and chemokine levels were significantly higher in exosomes isolated from GO-treated SKOV3 cells than in those isolated from control cells. SKOV3 cells pre-treated with N-acetylcysteine or GW4869 displayed a significant reduction in GO-induced exosome biogenesis and release. Furthermore, endocytic inhibitors decrease exosome biogenesis and release by impairing endocytic pathways. Conclusion: This study identifies GO as a potential tool for targeting the exosome pathway and stimulating exosome biogenesis and release. We believe that the knowledge acquired in this study can be potentially extended to other exosome-dominated pathologies and model systems. Furthermore, these nanoparticles can provide a promising means to enhance exosome production in SKOV3 cells.Keywords
This publication has 228 references indexed in Scilit:
- Green synthesis of graphene and its cytotoxic effects in human breast cancer cellsInternational Journal of Nanomedicine, 2013
- Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and diseaseRedox Biology, 2013
- Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2Particle and Fibre Toxicology, 2013
- Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity, 2013
- The ESCRT PathwayDevelopmental Cell, 2011
- Silver nanoparticles: Evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cellsToxicology Letters, 2011
- C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivoCell Death & Disease, 2011
- Survivin is released from cancer cells via exosomesApoptosis, 2010
- Inhibition of neutral sphingomyelinase‐2 perturbs brain sphingolipid balance and spatial memory in miceJournal of Neuroscience Research, 2010
- Use of Dynasore, the Small Molecule Inhibitor of Dynamin, in the Regulation of Endocytosis2008